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OBJECTIVE — To assess whether abdominal adiposity in early pregnancy is associated with
a higher risk of glucose intolerance at a later gestational stage.
RESEARCH DESIGN AND METHODS — Subcutaneous and visceral fat was measured
with ultrasonography at 12 weeks’ gestation. A 50-g glucose challenge test (GCT) was per-
formed between 24 and 28 weeks’ gestation. The risk of having a positive GCT (7.8 mmol/l)
was determined in association with subcutaneous and visceral adipose tissue depths above their
respective upper-quartile values relative to their bottom three quartile values.
RESULTS — Sixty-two women underwent GCTs. A visceral adipose tissue depth above the
upperquartilevaluewassigniﬁcantlyassociatedwithapositiveGCTinlaterpregnancy(adjusted
oddsratio16.9[95%CI1.5–194.6]).Noassociationswereseenforsubcutaneousadiposetissue.
CONCLUSIONS — Measurementofvisceraladiposetissuedepthinearlypregnancymaybe
associated with glucose intolerance later in pregnancy.
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M
aternalobesityisassociatedwitha
higher risk of gestational diabetes
mellitus (GDM) (1) and adverse
perinataloutcomes(2,3).Visceraladipos-
ity(4)maybetterpredicttheonsetoftype
2 diabetes, independent of BMI. Given
that GDM and type 2 diabetes share the
same risk factors (1) and GDM predates
theonsetoftype2diabetes(5),itislogical
to question whether high maternal vis-
ceral adiposity is associated with GDM.
We determined the reliability of ﬁrst-
trimester ultrasonography for measuring
subcutaneous and visceral adipose tissue
in pregnancy and whether either is pre-
dictive of a positive glucose challenge test
(GCT),whichiscommonlyusedtoscreen
for GDM later in pregnancy.
RESEARCH DESIGN AND
METHODS— We completed a pro-
spective cohort study at a single outpa-
tient ultrasound clinic at St. Michael’s
HospitalinToronto,Ontario,Canada,be-
tween January and May 2008. Women
with a singleton pregnancy were eligible
for the study at 11–14 weeks’ gestation.
Women with type 1 or type 2 diabetes
prior to pregnancy or with a previous his-
tory of GDM were excluded. Written and
informed consent was obtained, and the
study was approved by the hospital re-
search ethics board.
WeusedthetechniqueofArmelliniet
al. (6) to measure subcutaneous and vis-
ceral abdominal adipose tissue. A total of
62 patients were scanned on a Philips
iU22ultrasoundmachineusinga5-2or9
MHz probe. Subcutaneous fat depth was
measuredfromthesubcutaneousfatlayer
to the outer border of the rectus abdomi-
nus muscle at the level of the linea alba
(Fig. 1). Visceral fat depth was measured
from the inner border of the rectus abdo-
minus muscle at the level of the linea alba
to the anterior wall of the abdominal
aorta.
Two sonographers—one a perinatal
obstetrician and the other an experienced
ultrasound technologist—each per-
formedthreemeasurementsofthesubcu-
taneousandvisceralfatdepths.Eachrater
was masked to the other’s assessment,
and the measurements were recorded on
separate data collection sheets.
Intrarater reliability of ultrasonogra-
phy was determined for each rater using
three images of subcutaneous and three
images of visceral adipose tissue depth
per participant, respectively. Interob-
serverreliabilitywasseparatelycalculated
for subcutaneous and visceral adiposity.
Mean subcutaneous and visceral adi-
pose tissue depths were determined for
each participant, with the measures of
both sonographers pooled. The upper-
quartile value for each was considered el-
evated, and the three lowest quartile
values were treated as the referent. All
participants underwent a 50-g GCT at
24–28 weeks’ gestation. An abnormal
50-g GCT was deﬁned at a conventional
cut point: 7.8 mmol/l. Unadjusted and
adjusted ORs and 95% CIs expressed the
risk of an abnormal GCT in association
with an elevated subcutaneous and an el-
evated visceral adipose tissue depth,
respectively.
All P values were two-sided, and sig-
niﬁcance was set at a value of 0.05. Statis-
tical analyses were performed using SAS
(version 9; SAS Institute, Cary, NC).
RESULTS— Therewere62womenre-
cruited in total at mean  SD gestation
12.4  0.60 weeks and age 31.7  5.0
years. The median gravidity was 2.0, and
31 (50.0%) were of nonwhite ethnicity.
Mean prepregnancy BMI was 23.9  5.2
kg/m
2. Mean subcutaneous and visceral
adiposity tissue depths by ultrasonogra-
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and4.01.4cm(1.3–8.2),respectively.
The 50-g GCT was completed at 27.4 
1.4 weeks’ gestation.
Reliabilitymeasureswerebasedonall
62 women. The intraclass correlation co-
efﬁcient for intraobserver agreement of
visceral adiposity tissue measurement
was 0.94 (95% CI 0.91–0.96) for the
physician and 0.97 (0.95–0.98) for the
technologist. Similar results were seen for
subcutaneous adiposity measurement.
Lin’s concordance correlation coefﬁcient
forinterobserverreliability(betweenphy-
sician vs. technologist) was 0.79 (0.69–
0.88) for subcutaneous adiposity and
0.87 (0.82–0.93) for visceral adiposity.
Fifty-eightwomenformedthesample
used to analyze the relationship between
adiposity and subsequent GCT positivity.
No signiﬁcant associations were observed
betweentheupper-quartilesubcutaneous
adipose tissue depth and a positive GCT
(Table 1). However, an elevated visceral
adipose tissue depth was signiﬁcantly as-
sociated with a positive GCT (unadjusted
OR 17.3 [95% CI 1.8–163.8]). Even after
adjusting for maternal age and prepreg-
nancy BMI, the association remained sig-
niﬁcant (16.9 [1.5–194.6]).
CONCLUSIONS— Since we in-
cludedonly62women,ourriskestimates
were imprecise. We used a 50-g GCT as
anindicatorofglucoseintolerancelaterin
pregnancy rather than a more deﬁnitive
2-h75-goralglucosetolerancetest.How-
ever, a positive GCT is a reasonable pre-
dictor of GDM-related adverse perinatal
outcomes (7). A strength of this cohort
studyisthatweprospectivelyassessedab-
dominal adiposity at around the same
gestational age using a standardized pro-
tocol. All sonographers were masked to
eachother’smeasurements,andtheGCTs
were carried out without knowledge of
the abdominal depths.
Visceral adiposity predicts insulin re-
sistance (8) and diabetes (4) independent
of BMI, so it was logical for us to use ul-
trasonography to measure visceral fat in
relation to glucose intolerance in preg-
nancy. When used in nonpregnant pa-
tients, ultrasound has a correlation
coefﬁcient of between 0.55 (9) and 0.81
(10)andadiagnosticconcordanceof74%
with computed tomography (9) in the as-
sessment of visceral adiposity.
Maternal obesity, routinely deﬁned
as an elevated prepregnancy BMI, is as-
sociated with adverse pregnancy out-
comes (1–3,11). BMI may not accurately
differentiate between the contributions of
muscle and fat to body weight or of sub-
cutaneous versus visceral abdominal fat.
Epidemiologicalandmetabolicstudieshave
found that the adverse metabolic conse-
quences of excess fat depend largely on the
location of the fat (12,13), with centrally
located visceral fat more pathogenic than
subcutaneous adipose tissue (14). Our re-
sults are consistent with this concept.
Measurement of visceral adiposity
during a routine 11–14 weeks’ gestation
ultrasound might improve the perfor-
mance of screening for GDM (15). More-
over, identifying women at high risk for
GDM because of elevated visceral adipos-
itycouldleadtoeitherearlierscreeningor
earlier dietary and lifestyle modiﬁcations.
Clearly, this opens up a new avenue for
research.
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